Is AIKI or RYLD a better dividend investment in 2026?

AIKI currently yields 56.18% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: AIKI offers higher current income.

What is the dividend yield difference between AIKI and RYLD?

AIKI has a forward dividend yield of 56.18% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 44.04 percentage points.

Home › Compare › AIKI vs RYLD

AIKI vs RYLD: Dividend Comparison 2026

AIKI yields 56.18% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AIKI wins by $494.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

AIKI

● Live price

56.18%

Share price

$3.56

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$539.3K

Annual income

$119,796.88

Full AIKI calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — AIKI vs RYLD

📍 AIKI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AIKI	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AIKI + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AIKI pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AIKI

Annual income on $10K today (after 15% tax)

$4,775.28/yr

After 10yr DRIP, annual income (after tax)

$101,827.35/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, AIKI beats the other by $99,628.10/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AIKI + RYLD for your $10,000?

AIKI: 50%RYLD: 50%

100% RYLD50/50100% AIKI

Portfolio after 10yr

$291.9K

Annual income

$61,192.11/yr

Blended yield

20.96%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on AIKI right now

AIKI

Analyst Ratings

Buy

Consensus: Buy

Altman Z

0.9

Piotroski

6/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AIKI buys

RYLD buys

No recent congressional trades found for AIKI or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAIKIRYLD

Forward yield	56.18% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$539.3K ✓	$44.5K
Annual income after 10y	$119,796.88 ✓	$2,587.35
Total dividends collected	$441.4K ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: AIKI vs RYLD ($10,000, DRIP)

Year	AIKI Portfolio	AIKI Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$16,318	$5,617.98	$11,914	$1,213.65	+$4.4K → AIKI
2	$26,028	$8,567.67	$14,099	$1,351.30	+$11.9K → AIKI
3	$40,622	$12,771.79	$16,580	$1,494.55	+$24.0K → AIKI
4	$62,094	$18,628.85	$19,384	$1,642.61	+$42.7K → AIKI
5	$93,054	$26,613.05	$22,535	$1,794.70	+$70.5K → AIKI
6	$136,840	$37,273.01	$26,063	$1,950.00	+$110.8K → AIKI
7	$197,645	$51,226.14	$29,995	$2,107.69	+$167.7K → AIKI
8	$280,629	$69,148.09	$34,361	$2,266.99	+$246.3K → AIKI
9	$392,030	$91,757.54	$39,194	$2,427.12	+$352.8K → AIKI
10	$539,269	$119,796.88	$44,525	$2,587.35	+$494.7K → AIKI

AIKI vs RYLD: Complete Analysis 2026

AIKI — Stock

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.

Full AIKI Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this AIKI vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AIKI vs SCHD AIKI vs JEPI AIKI vs O AIKI vs KO AIKI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.